SNGX Logo

Soligenix, Inc. (SNGX) 

NASDAQ$2.3
Market Cap
$5.77M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
847 of 924
Rank in Industry
481 of 527

SNGX Insider Trading Activity

SNGX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00–
Sells
$00–

Related Transactions

No records found

About Soligenix, Inc.

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of â€¦

Insider Activity of Soligenix, Inc.

Over the last 12 months, insiders at Soligenix, Inc. have bought $0 and sold $0 worth of Soligenix, Inc. stock.

On average, over the past 5 years, insiders at Soligenix, Inc. have bought $17,899 and sold $2,701 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $8,866 was made by SCHABER CHRISTOPHER J (CHAIRMAN, CEO AND PRESIDENT) on 2022‑05‑18.

List of Insider Buy and Sell Transactions, Soligenix, Inc.

2022-05-18PurchaseSCHABER CHRISTOPHER JCHAIRMAN, CEO AND PRESIDENT
20,000
0.0466%
$0.44$8,866+23.81%
2022-05-18PurchaseStraube RichardSENIOR VICE PRESIDENT AND CMO
8,000
0.021%
$0.50$4,000+23.81%
2021-12-17PurchaseSCHABER CHRISTOPHER JCHAIRMAN, CEO AND PRESIDENT
7,000
<0.0001%
$0.74$5,179-13.05%
2021-12-15PurchaseGuarino Jonathan L.Senior Vice President and CFO
1,000
<0.0001%
$0.70$700-10.86%
2021-12-14PurchaseSCHABER CHRISTOPHER JChairman, CEO and President
10,000
0.0001%
$0.73$7,269-7.05%
2021-12-14PurchaseGuarino Jonathan L.Senior Vice President and CFO
10,000
0.0001%
$0.71$7,119-7.05%
2021-05-14SaleZELDIS JEROME Bdirector
3,000
<0.0001%
$0.90$2,701+1.43%
2021-05-14PurchaseZELDIS JEROME Bdirector
3,000
<0.0001%
$0.89$2,664+1.43%
2019-11-19PurchaseSCHABER CHRISTOPHER JChairman, CEO and President
10,770
0.0544%
$0.93$10,016+92.63%
2019-11-19PurchaseZELDIS JEROME Bdirector
2,000
0.0101%
$0.93$1,850+92.63%
2019-09-23PurchaseParks Diane L.director
14,940
0.0003%
$0.93$13,870+95.33%
2019-09-19PurchaseZELDIS JEROME Bdirector
4,000
<0.0001%
$0.94$3,740+93.21%
2019-04-22PurchaseSCHABER CHRISTOPHER JChairman, CEO and President
5,000
0.0001%
$0.72$3,577+47.89%
2019-04-22PurchaseZELDIS JEROME Bdirector
10,000
0.0002%
$0.73$7,274+47.89%
2018-10-18PurchaseSCHABER CHRISTOPHER JChairman, CEO and President
8,700
0.0002%
$1.17$10,177-22.88%
2018-10-17PurchasePearson Mark E.director
170,000
0.0046%
$1.16$197,200-13.90%
2018-08-22PurchaseSCHABER CHRISTOPHER JChairman, CEO and President
3,530
<0.0001%
$1.42$5,012-30.71%
2017-11-29SaleEssetifin SPA
16,416
0.0012%
$2.12$34,802-19.31%
2017-11-29PurchaseEssetifin SPA
293,510
0.0223%
$2.12$622,241-19.31%
2017-05-08SaleKIRK RANDAL J10 percent owner
11,576
0.0009%
$2.54$29,403-16.86%
Total: 56

Insider Historical Profitability

62.23%
CAVAZZA PAOLO10 percent owner
54227816
2160.9012%
$124.72M30
CAVAZZA CLAUDIO10 percent owner
54227816
2160.9012%
$124.72M30
BAM Management LLC10 percent owner
21766092
867.3478%
$50.06M11
Pearson Mark E.director
2500000
99.6214%
$5.75M10
KANZER STEVE Hdirector
1282203
51.094%
$2.95M10

Historical Insider Profitability vs. Competitors

$18,881,323
88
-48.96%
$4.47M
$296,936
37
-18.12%
$4M
$523,320
24
94.37%
$7.01M
$31,129
22
-11.96%
$6.19M
$51,865
17
-38.70%
$6.16M

SNGX Institutional Investors: Active Positions

Increased Positions7+116.67%11,648+17.62%
Decreased Positions2-33.33%47,192-71.39%
New Positions4New326New
Sold Out Positions2Sold Out47,192Sold Out
Total Postitions11+83.33%30,557-53.77%

SNGX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Geode Capital Management, Llc$60.000.87%26,094+7,729+42.09%2024-12-31
Morgan Stanley$9.000.13%3,816+3,592+1,603.57%2024-12-31
Ubs Group Ag$1.000.01%313+313New2024-12-31
Plante Moran Financial Advisors, Llc$1.000.01%30000%2024-12-31
Bank Of America Corp /De/$0<0.01%20+<1+5.26%2024-12-31
Jones Financial Companies Lllp$00%10+10New2024-12-31
Sbi Securities Co., Ltd.$00%2+2New2024-12-31
Cwm, Llc$00%1+<1New2024-12-31
Albion Financial Group /Ut$00%100%2024-12-31
Stephens Inc /Ar/$00%0-46,262Sold Out2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
2Strong BuyBuyHoldSellStrong Sell